SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-18-049635
Filing Date
2018-08-06
Accepted
2018-08-06 07:23:45
Documents
12
Period of Report
2018-08-06
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a18-18323_48k.htm 8-K 21587
2 EX-99.1 a18-18323_4ex99d1.htm EX-99.1 13663
3 GRAPHIC g183233mmi001.gif GRAPHIC 142568
4 GRAPHIC g183233mmi002.gif GRAPHIC 119302
5 GRAPHIC g183233mmi003.gif GRAPHIC 98270
6 GRAPHIC g183233mmi004.gif GRAPHIC 75130
7 GRAPHIC g183233mmi005.gif GRAPHIC 83820
8 GRAPHIC g183233mmi006.gif GRAPHIC 81522
9 GRAPHIC g183233mmi007.gif GRAPHIC 68007
10 GRAPHIC g183233mmi008.gif GRAPHIC 77512
11 GRAPHIC g183233mmi009.gif GRAPHIC 146337
12 GRAPHIC g183233mmi010.gif GRAPHIC 123342
  Complete submission text file 0001104659-18-049635.txt   1436842
Mailing Address 7707 GATEWAY BLVD., SUITE 140 NEWARK CA 94560-1160
Business Address 7707 GATEWAY BLVD., SUITE 140 NEWARK CA 94560-1160 (510) 474-0170
Protagonist Therapeutics, Inc (Filer) CIK: 0001377121 (see all company filings)

IRS No.: 980505495 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37852 | Film No.: 18993464
SIC: 2834 Pharmaceutical Preparations